COMPLEMENTARY VALUE OF 5 CARCINOMA-MARKERS FOR THE DIAGNOSIS OF MALIGNANT MESOTHELIOMA, ADENOCARCINOMA-METASTASIS, AND REACTIVE MESOTHELIUMIN SEROUS EFFUSIONS

Citation
M. Delahaye et al., COMPLEMENTARY VALUE OF 5 CARCINOMA-MARKERS FOR THE DIAGNOSIS OF MALIGNANT MESOTHELIOMA, ADENOCARCINOMA-METASTASIS, AND REACTIVE MESOTHELIUMIN SEROUS EFFUSIONS, Diagnostic cytopathology, 17(2), 1997, pp. 115-120
Citations number
44
Categorie Soggetti
Medical Laboratory Technology",Pathology
Journal title
ISSN journal
87551039
Volume
17
Issue
2
Year of publication
1997
Pages
115 - 120
Database
ISI
SICI code
8755-1039(1997)17:2<115:CVO5CF>2.0.ZU;2-B
Abstract
Cytological slides of serous fluids of 41 malignant mesotheliomas, 88 metastatic adenocarcinomas, and 25 reactive effusions were immunostain ed with the antibodies anti-CEA, MOC-31, Leu-M1, Ber-EP4, and B72.3. M ost mesotheliomas and all reactive fluids failed to stain with these a ntibodies. The sensitivity of the five markers to detect carcinoma cel ls differed remarkably. Especially MOC-31, Ber-EP4, and B72.3 stained with a high number of carcinoma cases and the complementary value of B er-EP4 and B72.3 to immunostain carcinoma cells was impressive: 94% of the metastatic adenocarcinoma cases reacted with Ber-EP4 or B72.3 in contrast to 1 of 41 malignant mesotheliomas. (C) 1997 Wiley-Liss, Inc.